Skip to main content

Wegovy maker Novo Nordisk down 4%, heads for worst day since October

Analysts pored over the details in its first-quarter results and monitored a potential rival weight loss treatment.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.